GlassScriptPhysician profile
Amanda A Duffy
NPI 1831601798
$2,079.98
in general payments reported to CMS, 2019-2025
22 companies · $15.71 in 2025
The $15.71 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,428 · 2022: $188 · 2023: $261 · 2024: $187 · 2025: $15.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $389.46 | 2021-2025 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, General - Therapies |
| Axonics, INC. | $332.26 | 2021-2024 | Axonics |
| Chugai Pharmaceutical Co., LTD. | $175.00 | 2022 | |
| Vertos Medical, INC. | $165.94 | 2021-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $149.92 | 2021 | |
| Abbvie INC. | $135.55 | 2021 | |
| Grt US Holding, INC. | $94.19 | 2021 | |
| Pfizer INC. | $75.16 | 2021-2023 | |
| Amgen INC. | $67.54 | 2021 | |
| Almatica Pharma LLC | $66.51 | 2021 | |
| Medtronic, INC. | $62.03 | 2021 | |
| Abbott Laboratories | $61.45 | 2021 | |
| Lilly USA, LLC | $54.51 | 2021 | |
| Tersera Therapeutics LLC | $49.62 | 2021 | |
| Acacia Pharma INC | $42.07 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $40.64 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $36.69 | 2021 | |
| Ethicon US, LLC | $24.51 | 2023 | Stratafix |
| Redhill Biopharma INC. | $16.56 | 2021 | |
| Phadia US INC. | $14.48 | 2024 | Immunocap |
| Supernus Pharmaceuticals, INC. | $13.24 | 2021 | |
| Si-Bone, INC. | $12.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Duffy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.